Literature DB >> 6271679

Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy.

R F Pass, M E Dworsky, R J Whitley, A M August, S Stagno, C A Alford.   

Abstract

Cell-mediated immune responses in 27 infants and children with cytomegalovirus (CMV) infection acquired between birth and 1 year of age were compared with responses in 13 children who had neonatal herpes simplex virus (HSV) infection. Infection was asymptomatic in 25 of 27 CMV-infected children; the 13 patients with HSV infection were all ill as newborns. The median age when studied was 46 months for children infected with CMV and 24 months for those infected with HSV. We measured lymphocyte transformation responses (LTRs) to CMV antigens in the former group and to HSV type 1 (HSV-1) (and in six cases to HSV-2) in the latter group, with the results expressed as a stimulation index. Based on the results in seropositive and seronegative adult control subjects, stimulation indexes of greater than or equal to 3 were considered indicative of a positive LTR. Among the CMV-infected children, a positive LTR was observed in 0 to 13 assays performed before 1 year of age, 3 of 8 assays performed between 1 and 4 years of age, and 9 of 15 assays performed over 4 years of age. In contrast, a positive LTR to HSV-1 was seen in 15 to 18 assays performed in children under 1 year of age and in 14 of 16 assays performed in survivors of neonatal HSV infection older than 1 year. Six HSV-2-infected patients were tested simultaneously 13 times with HSV-1 and HSV-2 antigens. Those patients under 6 months of age responded similarly to each antigen, whereas those who were older had significantly higher LTRs to HSV-2. Children with CMV infection that was acquired early had persistently diminished specific LTRs. In contrast, after neonatal HSV infection, LTRs to HSV were present even in infancy and became more specific for the infecting type with increasing age.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271679      PMCID: PMC350838          DOI: 10.1128/iai.34.1.166-170.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Cellular immune response in genital herpes simplex virus infection.

Authors:  L Corey; W C Reeves; K K Holmes
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

2.  Stimulation of human lymphocytes by Herpes simplex virus antigens.

Authors:  S E Starr; S A Karatela; S L Shore; A Duffey; A J Nahmias
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

3.  Late 19S rabbit antibody neutralization test for differentiating herpes simplex virus types 1 and 2.

Authors:  B Hampar; L M Martos; M Chakrabarty; M A Burroughs
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

4.  Type specific and type common antigens in cells infected with herpes simplex virus type 1 and on the surfaces of naked and enveloped particles of the virus.

Authors:  R W Honess; K L Powell; D J Robinson; C Sim; D H Watson
Journal:  J Gen Virol       Date:  1974-02       Impact factor: 3.891

5.  Impaired lymphocyte transformation response to cytomegalovirus and phytohemagglutinin in recipients of renal transplants: association with antithymocyte globulin.

Authors:  R F Pass; D W Reynolds; J D Whelchel; A G Diethelm; C A Alford
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

6.  Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis.

Authors:  M J Levin; C R Rinaldo; P L Leary; J A Zaia; M S Hirsch
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

7.  Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections.

Authors:  S Stagno; D W Reynolds; A Tsiantos; D A Fuccillo; W Long; C A Alford
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

8.  Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers.

Authors:  S E Starr; M D Tolpin; H M Friedman; K Paucker; S A Plotkin
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

9.  Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay.

Authors:  C Lopez; R J O'Reilly
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

10.  Incidence of cytomegaloviremia in blood-bank donors and in infants with congenital cytomegalic inclusion disease.

Authors:  R Mirkovic; J Werch; M A South; M Benyesh-Melnick
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

View more
  10 in total

1.  IgG subclass of anti-HSV antibodies following neonatal HSV infections.

Authors:  A Hayward; M Herberger; L Corey
Journal:  Eur J Pediatr       Date:  1986-09       Impact factor: 3.183

2.  Replication of cytomegalovirus in human thymic epithelial cells.

Authors:  K Numazaki; L DeStephano; I Wong; H Goldman; B Spira; M A Wainberg
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

3.  Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines.

Authors:  P J Leibson; M Hunter-Laszlo; G S Douvas; A R Hayward
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

4.  Viral loads in dual infection with HIV-1 and cytomegalovirus.

Authors:  Y S Boriskin; M Sharland; R Dalton; G duMont; J C Booth
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

5.  Infection of human thymic epithelial cells by human cytomegalovirus and other viruses: effect on secretion of interleukin 1-like activity.

Authors:  M A Wainberg; K Numazaki; L Destephano; I Wong; H Goldman
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

6.  Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection.

Authors:  Laura Gibson; Constance M Barysauskas; Margaret McManus; Sheryl Dooley; Daniele Lilleri; Donna Fisher; Tumul Srivastava; Don J Diamond; Katherine Luzuriaga
Journal:  J Clin Immunol       Date:  2015-02-25       Impact factor: 8.317

7.  Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections.

Authors:  L Pereira; S Stagno; M Hoffman; J E Volanakis
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.

Authors:  Suresh B Boppana; William J Britt
Journal:  Methods Mol Biol       Date:  2021

9.  The Innate Immune Response to Herpes Simplex Virus 1 Infection Is Dampened in the Newborn Brain and Can Be Modulated by Exogenous Interferon Beta To Improve Survival.

Authors:  Daniel Giraldo; Douglas R Wilcox; Richard Longnecker
Journal:  mBio       Date:  2020-05-26       Impact factor: 7.867

Review 10.  The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.

Authors:  Soren Gantt; William J Muller
Journal:  Clin Dev Immunol       Date:  2013-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.